Purpose of the articles posted in the blog is to share knowledge and occurring events for ecology and biodiversity conservation and protection whereas biology will be human’s security. Remember, these are meant to be conversation starters, not mere broadcasts :) so I kindly request and would vastly prefer that you share your comments and thoughts on the blog-version of this Focus on Arts and Ecology (all its past + present + future).

Premium Blogger Themes - Starting From $10
#Post Title #Post Title #Post Title

Indonesia approves China's Zifivax COVID-19 vaccine for emergency use

October 8, 2021 

Indonesia has approved a COVID-19 vaccine produced by Chinese company Anhui Zhifei Longcom Biopharmaceutical for emergency use, the country's food and drug agency BPOM said on Thursday.

The vaccine has an overall efficacy rate of about 81 percent, and its efficacy against the more transmissible Delta variant is 77.47 percent, BPOM's head Penny Lukito said, citing the results of the Phase-3 clinical trials of the vaccine involving 28,000 people in China, Uzbekistan, Pakistan, Ecuador and Indonesia.

In Indonesia, around 4,000 people aged between 18 and 59 years old were involved in the trials. 

In addition, Australia has approved China's Sinovac jabs for travelers as Canberra prepares to reopen international borders.

(Sources: China Report)

    Powered By Blogger